Ryo Morishima

Dr. Ryo Morishima


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Clinical Neurophysiology
Verified
Journal Article
Closed access
KBKota Bokuda
Kota Bokuda
TSToshio Shimizu
Toshio Shimizu
HKHideki Kimura
Hideki Kimura
RMRyo Morishima
Ryo Morishima
TKTsutomu Kamiyama
Tsutomu Kamiyama
EIEiji Isozaki
Eiji Isozaki

16 July 2019 in Journal of Neurology
Verified
Journal Article
Closed access
RMRyo Morishima
Ryo Morishima
KTKeisuke Takai
Keisuke Takai
TATetsuro Ando
Tetsuro Ando
YNYasuhiro Nakata
Yasuhiro Nakata
TSToshio Shimizu
Toshio Shimizu
MTMakoto Taniguchi
Makoto Taniguchi

17 July 2019 in Allergy
Verified
Journal Article
Closed access
PDF file
RMRyo Morishima
Ryo Morishima
SMShinji Motojima
Shinji Motojima
DTDaiki Tsuneishi
Daiki Tsuneishi
TKTakeshi Kimura
Takeshi Kimura
TNTamao Nakashita
Tamao Nakashita
HNHiroshi Nishino
Hiroshi Nishino

1 March 2018 in Neuromuscular Disorders
Verified
Journal Article
Closed access
SMShiro Matsubara
Shiro Matsubara
KBKota Bokuda
Kota Bokuda
YAYuri Asano
Yuri Asano
RMRyo Morishima
Ryo Morishima
KSKeizo Sugaya
Keizo Sugaya
INIchizo Nishino
Ichizo Nishino

18 December 2019 in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Verified
Journal Article
Closed access
TSToshio Shimizu
Toshio Shimizu
YNYuki Nakayama
Yuki Nakayama
AFAsuka Funai
Asuka Funai
RMRyo Morishima
Ryo Morishima
KHKentaro Hayashi
Kentaro Hayashi
EIEiji Isozaki
Eiji Isozaki
We describe a patient with sporadic amyotrophic lateral sclerosis (ALS) who showed progressive deterioration of sensory cortex excitability at the advanced stage, while using invasive ventilation. At the time of diagnosis, the patient showed enlarged N20 of the median nerve somatosensory evoked potential (SEP). Following ventilator use through tracheostomy, the patient gradually fell into a totally locked-in state for four years and the N20 showed progressive deterioration in the amplitude, which finally led to its loss. Magnetic resonance imaging (MRI) showed frontotemporal and mild parietal cortex atrophy, subcortical white matter hyperintensity and brainstem atrophy suggesting the involvement of the central sensory pathways. MRI and flash visual evoked potentials revealed that the occipital lobe was well-preserved throughout the course of the disease. This is the first case report of a physiological demonstration of multisystem neurodegeneration involving the central sensory pathway in a patient with advanced ALS and invasive ventilation use.

1 January 2018 in Internal Medicine
Verified
Journal Article
Open access
PDF file
RMRyo Morishima
Ryo Morishima
UNUtako Nagaoka
Utako Nagaoka
MNMasahiro Nagao
Masahiro Nagao
EIEiji Isozaki
Eiji Isozaki
Based on the hypothesis that autoimmunity plays a role in the pathogenesis of neuralgic amyotrophy (NA), immunotherapy is sometimes administered. Early intervention is recommended for a good prognosis. We herein report the case of a 55-year-old man who presented with neuralgia, weakness, and muscle atrophy in his right shoulder girdle and upper arm, which progressed for ten months following a marine sports accident. The patient was diagnosed with NA. His neurological deficits gradually improved after several courses of immunotherapy, suggesting that in addition to being effective for treating early-stage disease, immunotherapy may be effective for treating chronic cases.